TABLE 1.
Baseline characteristics
| Characteristic | Value by faldaprevir treatment duration |
|
|---|---|---|
| 12 wk (n = 81) | 24 wk (n = 79) | |
| Mean age, yrs (SD) | 48.1 (9.4) | 44.9 (11.9) |
| Male, n (%) | 54 (67) | 45 (57) |
| Body mass index, kg/m2, means (SD) | 25.3 (4.5) | 25.8 (4.1) |
| Race, n (%) | ||
| White | 77 (95) | 76 (96) |
| Asian | 2 (3) | 2 (3) |
| Black | 2 (3) | 1 (1) |
| Log10 HCV RNA, means (SD) | 6.53 (0.49) | 6.46 (0.61) |
| HCV RNA level, n (%) | ||
| <800,000 IU/ml | 9 (11) | 17 (22) |
| ≥800,000 IU/ml | 72 (89) | 62 (79) |
| HCV genotype,a n (%) | ||
| 1a | 40 (49) | 29 (37) |
| 1b | 39 (48) | 49 (62) |
| 1g | 1 (1) | 1 (1) |
| 6e | 1 (1) | 0 |
| Liver cirrhosis,b n (%) | ||
| Yes | 10 (12) | 10 (13) |
| No | 71 (88) | 69 (87) |
a
Based on NS3/4A sequencing.
b
Reported by the investigator.